A drug utilization study of psychotropic drugs prescribed in the psychiatry outpatient department of a tertiary care hospital

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 12, 2013, Pages 2759-2764

  Thakkar, Karan B ^a   Jain, Mangal M ^a   Billa, Gauri ^b   Joshi, Abhijit ^a   Khobragade, Akash A ^a  

^a SIR J J GROUP OF HOSPITALS   (India)

^b KEM HOSPITAL   (India)

Author keywords

ATC; DDD; Drug utilization; PDD; Psychopharmacology

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ARIPIPRAZOLE; CARBAMAZEPINE; CLONAZEPAM; CLOZAPINE; DESVENLAFAXINE; DIAZEPAM; ESCITALOPRAM; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LAMOTRIGINE; LITHIUM; LORAZEPAM; MIRTAZAPINE; OLANZAPINE; PIMOZIDE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SERTRALINE; SULPIRIDE; TRIFLUOPERAZINE; TRIHEXYPHENIDYL; VALPROATE SEMISODIUM; VALPROIC ACID; VENLAFAXINE;

ADOLESCENT; ADULT; AGED; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DEPRESSION; DRUG UTILIZATION; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; OUTPATIENT DEPARTMENT; PRACTICE GUIDELINE; PRESCRIPTION; PSYCHIATRY; RETROSPECTIVE STUDY; SCHIZOPHRENIA; TERTIARY HEALTH CARE; UNSPECIFIED SIDE EFFECT;

EID: 84890481636     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/6760.3885     Document Type: Article

References (52)

1. Strom BL. Pharmacoepidemiology. 4th ed. England: John Wiley and Sons; 2005.
2. WHO International Working Group for Drug Statistics Methodology. Introduction to drug utilization research [Internet]. Geneva: WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacology; 2003 [cited 2012 Nov 1]. Available from: http://www.whocc.no/filearchive/publications/drug_utilization_research.pdf.
3. World Health Organization. The World Health Report 2001- Mental Health: New understanding, new hope [Internet]. Geneva; 2001 [cited 2012 Sep 5]. Available from: http://www.who.int/whr/2001/en/.
4. Math SB, Chandrashekar CR, Bhugra D. Psychiatric epidemiology in India. The Indian journal of medical research [Internet]. 2007 Sep [cited 2012 Nov 21];126(3):183-92. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18037711.
5. Murthy R. Mental Health Programme in the 11th five year plan. The Indian Journal of Medical Research [Internet]. 2007 [cited 2012 Nov 21];11(June):707-12. Available from: http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2007;volume=125;issue=6;spage=707;epage=711;aulast=Murthy;type=0.
6. Sharma P, Das S, Deshpande S. An estimate of the monthly cost of two major mental disorders in an Indian metropolis. Indian J Psychiatry. 2006;48:143-8.
7. Brunton L, Lazo J, Parker K. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. McGraw-Hill publication; 2006. p. 401-500.
8. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ (Clinical research ed.) [Internet]. 2007 Oct 20 [cited 2012 Oct 29];335(7624):806-808. Available from: http://www.emgo.nl/kc/Analysis/statements/observationalstudies-lancet-2007.pdf.
9. World Health Organization. How to investigate drug use in health facilities: selected health use indicators [Internet]. WHO/ DAP/ 93. Geneva; 1993 [cited 2012 Sep 5]. p. 1-87. Available from: apps.who.int/medicinedocs/en/d/Js2289e/4.4.html
10. Drug Index: April - June. Vol. 16. Passi Publications; 2012.
11. Dean A, Sullivan K, Soe M. OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.3.1 [Internet]. 2011 [cited 2012 Oct 10]. Available from: www.OpenEpi.com.
12. ATC/DDD Index 2012 [Internet]. WHO Collaborating Centre for Drug Statistics Methodology Norwegian Institute of Public Health. 2012 [cited 2012 Sep 1]. Available from: http://www.whocc.no/atc_ddd_index/.
13. Patel V. Gender in Mental Health Research. Department of Gender, Women and Health Family and Community Health. [Internet]. World Health Organization. 2005 [cited 2012 Oct 12]. Available from: http://www.who.int/gender/documents/MentalHealthlast2.pdf.
14. Mohammed P, Mohamed E, Rajan S, Kumar K. Gender and mental health in Kerala [Internet]. Institute of Social Studies Trust. 2002 [cited 2012 Nov 2]. Available from: http://dspace.cigilibrary.org/jspui/handle/123456789/21040.
15. Earls F. Sex differences in psychiatric disorders: origins and developmental influences. Psychiatric developments [Internet]. 1987 Jan [cited 2012 Nov 2];5(1):1-23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3601929.
16. Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. Hill S, editor. PLoS medicine [Internet]. Public Library of Science; 2007 Oct [cited 2013 May 31];4(9):e283. Available from: http://dx.plos.org/10.1371/journal.pmed.0040283.
17. Piparva KG, Parmar DM, Singh P, Gajera MV, Trivedi HR. Drug utilization study of psychotropic drugs in outdoor patients in a teaching hospital. Indian journal of psychological medicine [Internet]. 2011 Jan [cited 2012 Oct 26];33(1):54-58. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195156/.
18. Kessler RC, Angermeyer M, Anthony JC, DE Graaf R, Demyttenaere K, Gasquet I, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World psychiatry: official journal of the World Psychiatric Association (WPA) [Internet]. 2007 Oct [cited 2012 Nov 2];6(3):168-76. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174588/.
19. Friedli L. Mental health, resilience and inequalities [Internet]. World Health Organisation; 2009 [cited 2012 Nov 2]. Available from: http://wellbeingsoutheast.org.uk/uploads/FB602619-E582-778A-9979F5BB826FDE9B/MentalHealth, Resilience and Inequalities.pdf.
20. Lahon K, Shetty H, Paramel A, Sharma G. A Retrospective Drug Utilization Study of Antidepressants in the Psychiatric Unit of a Tertiary Care Hospital. Journal of Clinical and Diagnostic Research [Internet]. 2011 [cited 2012 Nov 2];5(5):1069-1075. Available from: http://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2011&month=October&volume=5&issue=5&page=1069&id=1521.
21. Dutta SB, Dhasmana DC, Bhardwaj R. Psychotropic drug utilization pattern among patients with schizophrenia. Indian journal of psychiatry [Internet]. 2005 Oct [cited 2012 Nov 21];47(4):243-244. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921146/.
22. Nobili A, Garattini S, Mannucci P. Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium. Journal of Comorbidity. 2011;1:28-44.
23. Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading, but manageable. Clinical interventions in aging [Internet]. 2008 Jan [cited 2012 Nov 2];3(2):383-9. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2546482/.
24. Benjamin F, Banahan, Kolassa E. Arch Intern Med. 1997;157:2080-8. A Physician Survey on Generic Drugs and Substitution of Critical Dose Medications
25. Shrank W, Liberman J, Fischer M, Girdish C, Brennan T, Choudhry N. Physician Perceptions About Generic Drugs. The Annals of Pharmacotherapy. 2011;45:31-8.
26. Pope N. Generic Substitution of Narrow Therapeutic Index Drugs. US Pharm [Internet]. 2009;34(6):12-9. Available from: http://www.uspharmacist.com/ content/s/78/c/13854/.
27. Avasthi A, Aggarwal M, Grover S, Khan MKR. Research on anti-psychotics in India. Indian journal of psychiatry [Internet]. 2010 Jan;52(1):317-40. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146231/.
28. Kane J. Tardive Dyskinesia: Epidemiological and Clinical Presentation. In: Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology - 5th Generation of Progress [Internet]. Philadelphia, Pennsylvania: Lippincott, Williams, & Wilkins; 2002. Available from: http://www.acnp.org/g4/gn401000143/CH140.html.
29. Brasic JR. Tardive Dyskinesia [Internet]. Medscape Reference: Drugs, Diseases & Procedures. 2012 [cited 2012 Sep 3]. Available from: http://emedicine.medscape.com/article/1151826-overview#aw2aab6b4.
30. National List of Essential Medicines of India. [Internet]. Ministry of Health and Family welfare. Government of India. 2011 [cited 2012 Sep 1]. Available from: http://cdsco.nic.in/National List of Essential Medicine-finalcopy.pdf.
31. Lieberman J, Stroup T. The NIMH-CATIE Schizophrenia Study: What Did We Learn? Am J Psychiatry. [Internet]. 2011 [cited 2012 Nov 3];168(8):770-5. Available from: http://ajp.psychiatryonline.org/article.aspx?articleid=116011.
32. Jones PB, Barnes TRE, Davies L, Dunn G, Lloyd H, Hayhurst KP, et al. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Anti-psychotic Drugs in Schizophrenia Study (CUtLASS 1). Archives of general psychiatry [Internet]. 2006 Oct [cited 2012 Nov 3];63(10):1079-87. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17015810.
33. Dixon L, Perkins D, Calmes C. Guideline Watch: Practice Guideline for the treatment of patients with Schizophrenia [Internet]. American Psychiatric Association. 2009 [cited 2012 Oct 10]. Available from: http://psychiatryonline.org/content.aspx?bookid=28§ionid=1682213.
34. National Collaborating Centre for Mental Health. The Nice Guideline On Core Interventions In The Treatment And Management Of Schizophrenia In Adults In Primary And Secondary Care [Internet]. Royal College of Psychiatrists' Research Unit.The British Psychological Society. Leicester; 2010 [cited 2012 Sep 3]. Available from: http://www.nice.org.uk/nicemedia/pdf/CG82FullGuideline.pdf.
35. Kripke DF, Langer RD, Kline LE. Hypnotics' association with mortality or cancer: a matched cohort study. BMJ open. [Internet]. 2012 Jan [cited 2012 Nov 3];2(1):e000850. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3293137/.
36. Ashton H. Guidelines for the rational use of benzodiazepines. When and what to use. Drugs. [Internet]. 1994 Jul [cited 2012 Nov 3];48(1):25-40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7525193.
37. Practice guideline for the treatment of patients with major depressive disorder [Internet]. 3rd ed. Arlington (VA): American Psychiatric Association (APA); 2010. p. 152. Available from: http://www.psychiatryonline.com/pracGuide/ pracGuideChapToc_7.aspx.
38. NICE. Depression in adults (update) (CG90) [Internet]. National Institute for Health and Clinical Excellence. National Collaborating Centre for Mental Health; 2009 [cited 2012 Nov 3]. Available from: http://guidance.nice.org.uk/CG90.
39. Potter W, Hollester L. Antidepression Agents. In: Katzung B, editor. Basic and Clinical Pharmacology. 10th ed. Boston: McGraw-Hill; 2007. p. 475-88.
40. Research Center for Drug Evaluation and Drug Safety and Availability - FDA Drug Safety Communication. Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses [Internet]. Center for Drug Evaluation and Research; 2011 [cited 2012 Nov 3]. Available from: http://www.fda.gov/Drugs/DrugSafety/ucm297391.html.
41. Balon R, Mufti R, Arfken CL. A survey of prescribing practices for monoamine oxidase inhibitors. Psychiatric services (Washington, D.C.) [Internet]. 1999 Jul [cited 2012 Nov 3];50(7):945-7. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/10402617.
42. Kessing LV, Hellmund G, Geddes JR, Goodwin GM, Andersen PK. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. The British journal of psychiatry: the journal of mental science [Internet]. 2011 Jul [cited 2012 Nov 3];199(1):57-63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21593515.
43. Brunton L, Parker K, editors. Pharmacotherapy of Psychosis and Mania. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 12th ed. USA: McGraw-Hill; 2010.
44. Ventimiglia J, Kalali AH, McIntyre R. Treatment of bipolar disorder. Psychiatry (Edgmont) [Internet]. 2009 Oct [cited 2012 Nov 3];6(10):12-4. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2790396&tool=pmc entrez&rendertype=abstract.
45. Baldessarini RJ, Leahy L, Arcona S, Gause D, Zhang W, Hennen J. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatric services (Washington, D.C.) [Internet]. 2007 Jan;58(1):85-91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17215417.
46. NICE. Bipolar disorder (CG38) [Internet]. National Collaborating Centre for Mental Health; 2006 [cited 2012 Nov 3]. p. National Institute for Health and Clinical Excella. Available from: http://www.nice.org.uk/CG38.
47. Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology: The Fifth Generation of Progress [Internet]. Philadelphia, Pennsylvania: Lippincott, Williams, & Wilkins; 2002. Available from: http://www.acnp.org/g4/gn401000143/ CH140.html.
48. NICE. Anxiety (CG22) [Internet]. National Institute for Health and Clinical Excellence. National Collaborating Centre for Mental Health; 2011 [cited 2012 Nov 3]. Available from: http://guidance.nice.org.uk/CG113.
49. Yates W. Anxiety Disorders Treatment & Management [Internet]. Medscape Reference: Drugs, Diseases & Procedures. 2012 [cited 2012 Sep 3]. Available from: http://emedicine.medscape.com/article/286227-treatment#aw2aab6b6b4.
50. Theodorou A, Johnson K, Slezak J, Szychowski J. Recent Trends in Utilization of Antianxiety Medication. The American Journal of Pharmacy Benefits. 2009;1(4).
51. Ramanathan A, Shantha GB, Balan V. Suitability of a socio-economic scale for hospital psychiatric population. Indian journal of psychiatry. [Internet]. 1983 Jul [cited 2012 Nov 3];25(3):203-205. Available from: http://www.pubmedcentral.nih. gov/articlerender.fcgi?artid=3012318&tool=pmcentrez&rendertype=abstract.
52. ROBERTS R, SPITZER W, DELMORE T, SACKETT D. An Empirical Demonstration of Berkson's bias. J Chron Dis. [Internet]. 1978;31:119-128. Available from: http:// www.epidemiology.ch/history/PDF bg/Roberts RS et al.1978 an empirical demonstrationof berkson's bias.pdf.